2022-02-01 11166349 2023-01-31 11166349 2022-02-01 2023-01-31 11166349 2022-01-31 11166349 2021-02-01 2022-01-31 11166349 uk-core:WithinOneYear 2022-01-31 11166349 uk-core:WithinOneYear 2023-01-31 11166349 uk-bus:Director1 2022-02-01 2023-01-31 iso4217:GBP xbrli:pure 11166349 uk-bus:AuditExemptWithAccountantsReport 2022-02-01 2023-01-31 11166349 uk-bus:Micro-entities 2022-02-01 2023-01-31 11166349 uk-bus:FullAccounts 2022-02-01 2023-01-31 11166349 uk-bus:CompanyLimitedByGuarantee 2022-02-01 2023-01-31
FU'S subcutaneous needling association of europe
Registered Number:11166349
For the year ended 31 January 2023
England and Wales
Unaudited Financial Statements
2
For the year ended 31 January 2023
FU'S subcutaneous needling association of europe
Contents Page
1 to 2
Statement of Financial Position and Notes to the Accounts
3
11166349
Registered Number :
As at 31 January 2023
FU'S subcutaneous needling association of europe
Statement of Financial Position and Notes to the Accounts
£
£
2022
2023
£
£
9,780
9,230
Current assets
Prepayments and accrued income
(260)
(137)
Creditors: amounts falling due
within one year
(1)
-
9,092
9,520
Net current assets
Total assets less current liabilities
9,520
9,092
9,520
Net assets
9,092
9,520
9,092
Capital and reserves
Notes to the Accounts
Statutory Information
FU'S subcutaneous needling association of europe is a private limited company, limited by guarantee, domiciled in England and Wales,
registration number 11166349.
Registered address:
452 Milton Road
Cambridge
CB4 1ST
The presentation currency is £ sterling.
1. Average number of persons employed
During the year the average number of employees was 0
1 of 2
4
11166349
Registered Number :
For the year ended 31 January 2023
FU'S subcutaneous needling association of europe
Statement of Financial Position and Notes to the Accounts Continued
For the year ended 31 January 2023 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2023 in accordance with Section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year
and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and which otherwise comply
with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
JIDONG WU Director
These financial statements were approved and authorised for issue by the Board on 28 September 2023 and were signed by:
2 of 2